pubmed-article:10653329 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0021270 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0014792 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0026140 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0015684 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0000545 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0016157 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0486616 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0489829 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C1705313 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C1515273 | lld:lifeskim |
pubmed-article:10653329 | lifeskim:mentions | umls-concept:C1705501 | lld:lifeskim |
pubmed-article:10653329 | pubmed:issue | 1-2 | lld:pubmed |
pubmed-article:10653329 | pubmed:dateCreated | 2000-2-10 | lld:pubmed |
pubmed-article:10653329 | pubmed:abstractText | When term infants are fed standard formula that does not contain long-chain polyunsaturated fatty acids (LC-PUFA), they still show lower levels of docosahexaenoic acid (DHA) in red blood cell (RBC) phospholipids by several weeks or months postnatally. This study was designed in order to evaluate a potential alternative for supplementing term infant formulas with DHA by adding a high-DHA/low-eicosapentanoic acid fish oil to levels similar to that in human milk (0.3%). A total of 37 term infants were included in the study at 3 days of life. DHA concentrations remained stable between inclusion and 4 months of life at around 8% of the RBC phospholipids in the LC-PUFA enriched formula-fed group whereas it decreased significantly in the standard formula-fed group. In the human milk-fed group, RBC DHA concentrations at 4 months of age were significantly lower than that at birth and were significantly correlated with the duration of breast feeding (r = 0.85; P = 0.0002). A significant decrease of arachidonic acid between inclusion and 4 months of age was observed in the enriched formula-fed group and reached a mean value at 4 months, which was significantly lower than that observed in the human milk or standard formula-fed groups (P<0.0001). CONCLUSION: Supplementing term formulas with a high-docosahexaenoic acid/low-eicosapentanoic acid fish oil up to 4 months of age is efficient in improving docosahexaenoic acid status, however it increases the risk of impaired n-6 fatty acid status. | lld:pubmed |
pubmed-article:10653329 | pubmed:language | eng | lld:pubmed |
pubmed-article:10653329 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10653329 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10653329 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10653329 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10653329 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10653329 | pubmed:issn | 0340-6199 | lld:pubmed |
pubmed-article:10653329 | pubmed:author | pubmed-author:SalleB LBL | lld:pubmed |
pubmed-article:10653329 | pubmed:author | pubmed-author:ClarisOO | lld:pubmed |
pubmed-article:10653329 | pubmed:author | pubmed-author:LapillonneAA | lld:pubmed |
pubmed-article:10653329 | pubmed:author | pubmed-author:BrossardNN | lld:pubmed |
pubmed-article:10653329 | pubmed:author | pubmed-author:ReygrobelletB... | lld:pubmed |
pubmed-article:10653329 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10653329 | pubmed:volume | 159 | lld:pubmed |
pubmed-article:10653329 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10653329 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10653329 | pubmed:pagination | 49-53 | lld:pubmed |
pubmed-article:10653329 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:10653329 | pubmed:meshHeading | pubmed-meshheading:10653329... | lld:pubmed |
pubmed-article:10653329 | pubmed:meshHeading | pubmed-meshheading:10653329... | lld:pubmed |
pubmed-article:10653329 | pubmed:meshHeading | pubmed-meshheading:10653329... | lld:pubmed |
pubmed-article:10653329 | pubmed:meshHeading | pubmed-meshheading:10653329... | lld:pubmed |
pubmed-article:10653329 | pubmed:meshHeading | pubmed-meshheading:10653329... | lld:pubmed |
pubmed-article:10653329 | pubmed:meshHeading | pubmed-meshheading:10653329... | lld:pubmed |
pubmed-article:10653329 | pubmed:meshHeading | pubmed-meshheading:10653329... | lld:pubmed |
pubmed-article:10653329 | pubmed:meshHeading | pubmed-meshheading:10653329... | lld:pubmed |
pubmed-article:10653329 | pubmed:meshHeading | pubmed-meshheading:10653329... | lld:pubmed |
pubmed-article:10653329 | pubmed:articleTitle | Erythrocyte fatty acid composition in term infants fed human milk or a formula enriched with a low eicosapentanoic acid fish oil for 4 months. | lld:pubmed |
pubmed-article:10653329 | pubmed:affiliation | Department of Neonatology, Hopital Edouard Herriot, Lyon, France. | lld:pubmed |
pubmed-article:10653329 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10653329 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10653329 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:10653329 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |